Drugs / PRP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05567081 | Jun 2021 → Apr 2022 | ulnar neuropathy | Tanta University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05567081 ↗ |
| Modality | Protein / enzyme biologic | “3 cm of autologous platelet rich plasma injected once around the thickest part of ulnar nerve.” NCT05567081 ↗ |
| Route | Other | “Deep perineural injection with 3ml PRP at the thickest part of the ulnar nerve.” NCT05567081 ↗ |